Markets Wake Up to M&A, AI Uncertainty, and a Recall Bombshell

GSK's $10.6B Deal Steals the Morning

GSK agreed to buy Nuvalent for $10.6 billion this morning. The deal prices shares at $124 — a 40% premium to Friday's close. It is one of the largest pharma acquisitions of the year. M&A activity in biotech is heating up fast.

Apple's AI Reveal Raises More Questions

AAPL unveiled its new Siri AI features at WWDC overnight. But analysts are already asking whether Apple has the technical depth to compete. Gene Munster called it out directly. Apple carries minimal short interest, yet scepticism is building around AI execution. NVDA and INTC options traders, meanwhile, are stacking call bets into the summer — semiconductors remain the AI infrastructure play of choice.

BP Governance Chaos Unsettles Europe

BP is facing pressure from shareholders after the ousting of its chair. Investors want answers. The FT flagged the story this morning. BP's governance crisis adds to a difficult period for the European energy sector.

Stellantis Recall Hits 1 Million Vehicles

Stellantis faces a recall of over 1 million Jeep Wrangler and Gladiator vehicles. The issue is a fire risk from overheating power steering wiring. It is the latest in a long line of operational headwinds for the automaker.

Earnings Week Begins

Tonight brings results from CASY, CBRL, and SJM. Tuesday's main event is ORCL, with Wall Street focused entirely on AI commentary. ADBE and LEN follow on Wednesday. Short sellers hold minimal positions in both Oracle and Adobe — bears are not betting on misses.